ALDH1A1 and metabolic dysfunction-associated steatotic liver disease: Further studies in NAFLD patients are needed to assess retinaldehyde in the liver and determine its relation with ALDH1A1 and ALDH1A3 expression as well as implications for the NAFLD pathogenesis.